Palm Therapeutics

Palm Therapeutics develops small-molecule therapies for currently untreatable diseases by targeting protein palmitoylation, an essential modulator of disease progression. The company’s technology allows for the development of uniquely potent and protein-selective small molecule palmitoylation inhibitors. Drug-induced selective depalmitoylation makes it possible to inhibit proteins that couldn’t previously be targeted.